Pharmacodynamics and clinical use of guanethidine, bretylium and methyldopa
- 1 January 1962
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 9 (1), 107-115
- https://doi.org/10.1016/0002-9149(62)90104-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Prolonged Treatment of Hypertension with GuanethidinePublished by American Medical Association (AMA) ,1961
- CLINICAL PHARMACOLOGY OF BRETYLIUM TOSYLATE: PRELIMINARY OBSERVATIONSAnnals of the New York Academy of Sciences, 1960
- THE CIRCULATORY EFFECTS OF BRETYLIUM TOSYLATE AND GUANETHIDINEThe Lancet, 1960
- Effects of Bretylium Tosylate on Blood-pressure, Cardiac Output, and Renal Function in HypertensionBMJ, 1960
- Selective Inhibition of the Sympathetic Nervous System in Man with Bretylium Tosylate, a New Antihypertensive AgentCirculation, 1960
- Circulatory Effects of GuanethidineCirculation, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- BRETYLIUM TOSYLATE IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1960
- GUANETHIDINE: HYPOTENSIVE DRUG WITH PROLONGED ACTIONThe Lancet, 1959
- A NEW, POTENT ANTIHYPERTENSIVE DRUGJAMA, 1959